Eterna Therapeutics
ERNA
#9563
Rank
S$36.81 M
Marketcap
$0.72
Share price
-16.06%
Change (1 day)
-46.96%
Change (1 year)

P/S ratio for Eterna Therapeutics (ERNA)

P/S ratio as of November 2024 (TTM): 169

According to Eterna Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -3.21. At the end of 2024 the company had a P/S ratio of 61.1.

P/S ratio history for Eterna Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202461.1-57.21%
2023143
2022N/A
2021N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
1.12-99.33%๐Ÿ‡บ๐Ÿ‡ธ USA
> 1000 948.69%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
2.27-98.65%๐Ÿ‡ซ๐Ÿ‡ท France
9.74-94.23%๐Ÿ‡บ๐Ÿ‡ธ USA
0.2169-99.87%๐Ÿ‡ฆ๐Ÿ‡บ Australia
1.19-99.30%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel